Aiforia signs a local agreement with Siemens Healthineers Finland
Aiforia Technologies Plc, Press Release, October 22, 2025 at 10:30 a.m. EEST
Aiforia Technologies, a leading Finnish provider of deep learning AI solutions for digital pathology, has entered into a local agreement with Siemens Healthineers Finland. The partnership focuses on joint co-marketing and sales efforts, leveraging Siemens Healthineers Finland’s strong regional network and expertise in healthcare technology. Together, the companies aim to accelerate the adoption of AI in pathology and contribute to the advancement of precision diagnostics in Finland.
The collaboration builds on the broader European partnership between Aiforia and Siemens Healthineers, announced last month. Through this local agreement, Siemens Healthineers Finland will integrate Aiforia’s AI-powered solutions into its offering, supporting Finnish healthcare providers in their digital transformation and enhancing diagnostic workflows in pathology.
“We’re excited to announce a new local partnership with Aiforia, building on Siemens Healthineers’ global strategic collaboration. Guided by our mission to pioneer breakthroughs in healthcare, we aim to lead the way toward AI-powered digital pathology in Finland. This partnership marks an important step in shaping the future of healthcare,” says Jarno Eskelinen, CEO, Siemens Healthineers Finland.
“We are proud to announce our collaboration with Siemens Healthineers also in Finland. This strategic partnership represents a significant step forward in our shared commitment to modernizing the field of pathology and, ultimately, enhancing the standard of patient care across the region”, says Jukka Tapaninen, CEO of Aiforia.
Further inquiries
Jukka Tapaninen, CEO, Aiforia Technologies Plc
tel. +33 61 041 6686
https://investors.aiforia.com/
Certified Adviser
UB Corporate Finance Ltd
ubcf@unitedbankers.fi
About Aiforia
Aiforia is a trusted provider of deep learning artificial intelligence (AI) solutions for pathology. Aiforia delivers advanced software solutions that elevate diagnostic capabilities in image analysis, empowering remarkable medical discoveries both today and in the future. With thousands of AI models developed for research use and several diagnostic solutions deployed, Aiforia is making a significant impact on pathology and healthcare. In Europe, Aiforia is the leading provider of CE-IVD marked AI-powered solutions for digital pathology.
Founded in 2013, Aiforia is a publicly traded company with a global presence and thousands of users worldwide. Headquartered in Helsinki, Finland, the company also operates subsidiaries in the United States and France, and maintains a network of local representatives across Europe and North America. Aiforia’s diverse team includes experienced AI and software developers, pathologists, medical scientists, and a dedicated commercial team. Together, they are transforming pathology through AI, enabling better care for every patient.
Find out more at www.aiforia.com
SOURCE: Aiforia
